AKR1B1 and diabetes mellitus: Contributing factors [including diabetes-induced overexpression of reactive oxygen species (ROS); secretion of inflammatory cytokines; increased aldose reductase (AKR1B1) substrate conversion; and activation of protein kinase C β, δ, and θ] accelerate the occurrence of MI (21).